Terug
62
3
Ook genoteerd als
DQJCF
OTC
Dagbereik
€ 12,22
€ 12,28
52-Weeksbereik
€ 9,49
€ 15,98
Volume
10.916
50D / 200D Gem.
€ 12,45
/
€ 12,95
Vorige Slotkoers
€ 12,35
Koershistorie
Financiële Trends
Sectorvergelijking
vs Consumer Defensive sector mediaan (329 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 0,2 | 10,5 |
| P/B | 0,0 | 1,2 |
| ROE % | 15,8 | 12,3 |
| Net Margin % | 4,0 | 5,3 |
| Rev Growth 5Y % | 7,1 | 5,5 |
| D/E | 0,7 | 0,6 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
€ 0,00
€ 0,00 – € 0,00
|
2500 B | 0 |
| FY2026 |
€ 0,00
€ 0,00 – € 0,00
|
2400 B | 0 |
Belangrijkste Punten
Revenue grew 7,08% annually over 5 years — modest growth
ROE of 15,80% — decent returns on equity
Generating 79,84B in free cash flow
P/E of 0,20 — trading at a low valuation
PEG of 0,13 suggests growth is underpriced
Cash machine — converts 88,20% of earnings into free cash flow
Groei
Revenue Growth (5Y)
7,08%
Revenue (1Y)7,24%
Earnings (1Y)2,04%
FCF Growth (3Y)0,92%
Kwaliteit
Return on Equity
15,80%
ROIC11,59%
Net Margin4,03%
Op. Margin7,22%
Veiligheid
Debt / Equity
0,73
Current Ratio1,20
Interest Coverage25,35
Waardering
P/E Ratio
0,20
P/B Ratio0,03
EV/EBITDA1,78
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7,24% | Revenue Growth (3Y) | 7,71% |
| Earnings Growth (1Y) | 2,04% | Earnings Growth (3Y) | 16,96% |
| Revenue Growth (5Y) | 7,08% | Earnings Growth (5Y) | 13,92% |
| Profitability | |||
| Revenue (TTM) | 2,25T | Net Income (TTM) | 90,51B |
| ROE | 15,80% | ROA | 5,99% |
| Gross Margin | 31,90% | Operating Margin | 7,22% |
| Net Margin | 4,03% | Free Cash Flow (TTM) | 79,84B |
| ROIC | 11,59% | FCF Growth (3Y) | 0,92% |
| Safety | |||
| Debt / Equity | 0,73 | Current Ratio | 1,20 |
| Interest Coverage | 25,35 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 0,20 | P/B Ratio | 0,03 |
| P/S Ratio | 0,01 | PEG Ratio | 0,13 |
| EV/EBITDA | 1,78 | Dividend Yield | 0,02% |
| Market Cap | 18,33B | Enterprise Value | 288,96B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,25T | 2,10T | 1,94T | 1,83T | 1,71T |
| Net Income | 90,51B | 88,70B | 66,17B | 61,93B | 53,73B |
| EPS (Diluted) | 60,38 | 29,62 | 22,13 | 20,48 | 16,90 |
| Gross Profit | 716,73B | 662,90B | 600,39B | 543,39B | 497,32B |
| Operating Income | 162,30B | 140,19B | 105,26B | 88,69B | 81,31B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,51T | 1,50T | 1,48T | 1,38T | 1,37T |
| Total Liabilities | 886,98B | 951,41B | 1,02T | 984,43B | 931,49B |
| Shareholders' Equity | 607,84B | 537,94B | 454,03B | 392,49B | 418,88B |
| Total Debt | 442,59B | 500,70B | 612,72B | 614,37B | 555,63B |
| Cash & Equivalents | 171,96B | 172,72B | 242,09B | 176,78B | 157,52B |
| Current Assets | 527,99B | 513,43B | 551,84B | 486,53B | 495,50B |
| Current Liabilities | 441,59B | 419,22B | 368,42B | 326,38B | 353,55B |
Strategiescores
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#193 of 1052
#644 of 670
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026
Ingestapt
Contrarian Investing (David Dreman)
Mar 24, 2026